Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Reducing HPV-associated cancer globally.

Lowy DR, Schiller JT.

Cancer Prev Res (Phila). 2012 Jan;5(1):18-23. doi: 10.1158/1940-6207.CAPR-11-0542. Review.

2.

HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.

Palefsky JM, Giuliano AR, Goldstone S, Moreira ED Jr, Aranda C, Jessen H, Hillman R, Ferris D, Coutlee F, Stoler MH, Marshall JB, Radley D, Vuocolo S, Haupt RM, Guris D, Garner EI.

N Engl J Med. 2011 Oct 27;365(17):1576-85. doi: 10.1056/NEJMoa1010971.

3.

Prevalence and type distribution of human papillomavirus infection in women from North Sardinia, Italy.

Piana A, Sotgiu G, Castiglia P, Pischedda S, Cocuzza C, Capobianco G, Marras V, Dessole S, Muresu E.

BMC Public Health. 2011 Oct 11;11:785. doi: 10.1186/1471-2458-11-785.

4.

Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies.

Tota JE, Chevarie-Davis M, Richardson LA, Devries M, Franco EL.

Prev Med. 2011 Oct;53 Suppl 1:S12-21. doi: 10.1016/j.ypmed.2011.08.017. Review.

PMID:
21962466
5.

Human papillomavirus: science and technologies for the elimination of cervical cancer.

Bosch FX.

Expert Opin Pharmacother. 2011 Oct;12(14):2189-204. doi: 10.1517/14656566.2011.596527. Epub 2011 Jul 15. Review.

PMID:
21756205
6.

Economic burden of HPV-related cancers in France.

Borget I, Abramowitz L, Mathevet P.

Vaccine. 2011 Jul 18;29(32):5245-9. doi: 10.1016/j.vaccine.2011.05.018. Epub 2011 May 25.

PMID:
21616117
7.

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males.

Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, Chang YH, Ferris D, Rouleau D, Bryan J, Marshall JB, Vuocolo S, Barr E, Radley D, Haupt RM, Guris D.

N Engl J Med. 2011 Feb 3;364(5):401-11. doi: 10.1056/NEJMoa0909537. Erratum in: N Engl J Med. 2011 Apr 14;364(15):1481.

8.

Economic burden of anal cancer management in France.

Abramowitz L, Rémy V, Vainchtock A.

Rev Epidemiol Sante Publique. 2010 Oct;58(5):331-8. doi: 10.1016/j.respe.2010.06.165.

PMID:
20869182
9.

Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark.

Olsen J, Jepsen MR.

Int J Technol Assess Health Care. 2010 Apr;26(2):183-91. doi: 10.1017/S0266462310000085.

PMID:
20392322
10.

Beyond cervical cancer: burden of other HPV-related cancers among men and women.

Chaturvedi AK.

J Adolesc Health. 2010 Apr;46(4 Suppl):S20-6. doi: 10.1016/j.jadohealth.2010.01.016.

PMID:
20307840
11.

A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions.

Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Dillner J, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Maansson R, Lu S, Vuocolo S, Hesley TM, Saah A, Barr E, Haupt RM.

Cancer Prev Res (Phila). 2009 Oct;2(10):868-78. doi: 10.1158/1940-6207.CAPR-09-0031. Epub 2009 Sep 29.

12.

Human papillomavirus prevalence and type distribution in penile carcinoma.

Miralles-Guri C, Bruni L, Cubilla AL, Castellsagué X, Bosch FX, de Sanjosé S.

J Clin Pathol. 2009 Oct;62(10):870-8. doi: 10.1136/jcp.2008.063149. Epub 2009 Aug 25. Review.

PMID:
19706632
13.

Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions.

Hoots BE, Palefsky JM, Pimenta JM, Smith JS.

Int J Cancer. 2009 May 15;124(10):2375-83. doi: 10.1002/ijc.24215. Review.

14.

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis.

De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S.

Int J Cancer. 2009 Apr 1;124(7):1626-36. doi: 10.1002/ijc.24116.

15.

Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions.

Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjose S, Kjaer SK, Muñoz N, Schiffman M, Bosch FX.

Vaccine. 2008 Aug 19;26 Suppl 10:K17-28. doi: 10.1016/j.vaccine.2008.06.021. Review.

16.

The economic burden of noncervical human papillomavirus disease in the United States.

Hu D, Goldie S.

Am J Obstet Gynecol. 2008 May;198(5):500.e1-7. doi: 10.1016/j.ajog.2008.03.064. Review.

17.

Chapter 2: The burden of HPV-related cancers.

Parkin DM, Bray F.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/11-25. Review.

PMID:
16949997
18.

Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities.

Rousseau MC, Villa LL, Costa MC, Abrahamowicz M, Rohan TE, Franco E.

Sex Transm Dis. 2003 Jul;30(7):581-7.

PMID:
12838088
19.

Modeling risk using generalized linear models.

Blough DK, Madden CW, Hornbrook MC.

J Health Econ. 1999 Apr;18(2):153-71.

PMID:
10346351
20.

Predicting the cost of illness: a comparison of alternative models applied to stroke.

Lipscomb J, Ancukiewicz M, Parmigiani G, Hasselblad V, Samsa G, Matchar DB.

Med Decis Making. 1998 Apr-Jun;18(2 Suppl):S39-56.

PMID:
9566466

Supplemental Content

Support Center